FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

395887002: Somatropin(rmc) (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1469827012 Somatropin(rmc) (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1489524017 Somatropin(rmc) en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2692114014 Somatropin (rmc) en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Somatropin(rmc) Is a Somatropin (substance) false Inferred relationship Some
    Somatropin(rmc) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Anterior pituitary hormone (disposition) false Inferred relationship Some
    Somatropin(rmc) Is a Recombinant human growth hormone false Inferred relationship Some
    Somatropin(rmc) Is a Somatropin and somatropin agonist false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    somatropine (rmc) 24 UI (8 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatropin(rmc) Inferred relationship Some
    somatropine (rmc) 10 UI (3,33 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatropin(rmc) Inferred relationship Some
    somatropine (rmc) 4 UI (1,33 mg), fiole de poudre et solvant pour solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatropin(rmc) Inferred relationship Some
    Product containing precisely somatropin(rmc) 1.33 milligram/1 vial powder for conventional release solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Somatropin(rmc) Inferred relationship Some 1
    Product containing precisely somatropin(rmc) 1.33 milligram/1 vial powder for conventional release solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Somatropin(rmc) Inferred relationship Some 1
    Product containing precisely somatropin(rmc) 3.33 milligram/1 vial powder for conventional release solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Somatropin(rmc) Inferred relationship Some 1
    Product containing precisely somatropin(rmc) 3.33 milligram/1 vial powder for conventional release solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Somatropin(rmc) Inferred relationship Some 1
    Product containing somatropin(rmc) in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatropin(rmc) Inferred relationship Some 1
    Product containing somatropin(rmc) (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatropin(rmc) Inferred relationship Some 1
    Product containing only somatropin(rmc) (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatropin(rmc) Inferred relationship Some 1
    Product containing only somatropin(rmc) in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Somatropin(rmc) Inferred relationship Some 1

    Reference Sets

    Concept inactivation indicator reference set

    MOVED TO association reference set

    Back to Start